Ledipasvir/sofosbuvir

Property	Value
rdf:type	World Health Organization essential medicine owl:NamedIndividual Combination drug NS5A inhibitor Drug granted breakthrough therapy designation NS5B (polymerase) inhibitor
rdfs:label	Ledipasvir/sofosbuvir
owl:sameAs	dbr:Ledipasvir/sofosbuvir
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:NS5A_inhibitors http://en.wikipedia.org/wiki/Category:NS5B_(polymerase)_inhibitors http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines http://en.wikipedia.org/wiki/Category:Combination_drugs http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation
skos:prefLabel	Ledipasvir/sofosbuvir
skos:altLabel	combination with sofosbuvir Harvoni Ledipasvir/Sofosbuvir Sofosbuvir and ledipasvir ledipasvir/sofosbuvir
clgo:alternativeName	Harvoni, Hepcinat-LP, others
clgo:kegg	D10578
clgo:medlinePlus	a614051
clgo:pubchem	72734365
is clgo:product of	Gilead Sciences

About: clgr:Ledipasvir/sofosbuvir